Globus Medical Inc (GMED)
70.59
+0.07
(+0.10%)
USD |
NYSE |
Sep 27, 16:00
70.59
0.00 (0.00%)
After-Hours: 20:00
Globus Medical Research and Development Expense (Annual): 124.01M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 124.01M |
| December 31, 2022 | 73.02M |
| December 31, 2021 | 97.35M |
| December 31, 2020 | 84.52M |
| December 31, 2019 | 60.07M |
| December 31, 2018 | 55.50M |
| December 31, 2017 | 43.68M |
| December 31, 2016 | 44.53M |
| Date | Value |
|---|---|
| December 31, 2015 | 36.31M |
| December 31, 2014 | 31.17M |
| December 31, 2013 | 26.87M |
| December 31, 2012 | 27.93M |
| December 31, 2011 | 23.46M |
| December 31, 2010 | 21.31M |
| December 31, 2009 | 20.52M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
60.07M
Minimum
2019
124.01M
Maximum
2023
87.79M
Average
84.52M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Haemonetics Corp | 54.44M |
| Stryker Corp | 1.388B |
| Abbott Laboratories | 2.741B |
| Alphatec Holdings Inc | 70.12M |